DiamondTemp Ablation System

Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation

January 29, 2021 Medtronic plc has received U.S. Food and Drug Administration (FDA) approval of the DiamondTemp Ablation system which treats patients with recurrent, symptomatic paroxysmal atrial fibrillation and who have been unresponsive to drug therapy. The DiamondTemp system is the...
Exit mobile version